巴拿马 - 英文 - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pierre fabre medicament - busulfan - busulfan....60.00 mg

巴拿马 - 英文 - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pierre fabre medicament - vinorelbina (tartrato) - vinorelbina (tartrato)....30 mg

巴拿马 - 英文 - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pierre fabre medicament - vinorelbina (tartrato) - vinorelbina (tartrato)....20.00 mg.

巴拿马 - 英文 - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pierre fabre medicament - busulfan - busulfan....60 mg

新加坡 - 英文 - HSA (Health Sciences Authority)

dch auriga singapore - ear, nose & throat - pierre fabre nasodrill thermal water nasal spray is an isotonic solution made from thermal luchon water (a french hydrotherapy centre producing water extremely rich in sulphur) intended for cleansing the nasal passages, especially in the event of chronic or recurrent infection such as rhinitis or rhinopharyngitis. nasodrill exerts a mechanical washing action which clears the nose and helps to maintain the physiological activity of the nasal membranes.

新加坡 - 英文 - HSA (Health Sciences Authority)

pierre fabre singapore pte ltd - encorafenib - capsule - encorafenib 50mg

新加坡 - 英文 - HSA (Health Sciences Authority)

pierre fabre singapore pte ltd - encorafenib - capsule - encorafenib 75mg

新加坡 - 英文 - HSA (Health Sciences Authority)

pierre fabre singapore pte ltd - binimetinib - tablet, film coated - binimetinib 15mg

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

pierre fabre australia pty ltd - vinorelbine tartrate, quantity: 110.8 mg (equivalent: vinorelbine, qty 80 mg) - capsule, soft - excipient ingredients: ethanol; purified water; glycerol; macrogol 400; gelatin; iron oxide yellow; titanium dioxide; medium chain triglycerides; ascorbyl palmitate; phosphatidyl choline; dl-alpha-tocopherol; sorbitol; 1,4-sorbitan; mannitol; hydrogenated starch hydrosylate; hypromellose; propylene glycol; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal - non-small cell lung cancer: vinorelbine pierre fabre is indicated for the first line treatment of advanced non-small cell lung cancer, as a single agent or in combination.,breast cancer: vinorelbine pierre fabre is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

pierre fabre australia pty ltd - vinorelbine tartrate, quantity: 41.55 mg (equivalent: vinorelbine, qty 30 mg) - capsule, soft - excipient ingredients: ethanol; purified water; glycerol; macrogol 400; gelatin; iron oxide red; titanium dioxide; medium chain triglycerides; sorbitol; 1,4-sorbitan; mannitol; hydrogenated starch hydrosylate; ascorbyl palmitate; phosphatidyl choline; dl-alpha-tocopherol; hypromellose; propylene glycol; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal - non-small cell lung cancer: vinorelbine pierre fabre is indicated for the first line treatment of advanced non-small cell lung cancer, as a single agent or in combination.,breast cancer: vinorelbine pierre fabre is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.